BLOGGERS: MARK SCHOLZ, MD & RALPH H. BLUM

The co-authors of Invasion of the Prostate Snatchers, blog alternate posts weekly. We invite you to post your comments.
Showing posts with label crestor. Show all posts
Showing posts with label crestor. Show all posts

Tuesday, May 12, 2015

Metformin and Statins for Prostate Cancer

BY MARK SCHOLZ, MD

As an internist and an oncologist, throughout my long career treating prostate cancer patients, I have periodically been asked by patients, “What do you do?  Surgeons (urologists) operate, and radiation doctors give radiation, but what do prostate oncologists do?”  My day-to-day, bread and butter is giving medical advice and prescribing oral medications. Unfortunately, I think this leads to some patients seeing me as a “pill pusher.” As such, I think I need to explain my motives for recommending the use of metformin and statins to my patients with prostate cancer.

One of the things that the last 20 years of my career treating prostate cancer has taught me is that a good diet has a favorable effect on inhibiting prostate cancer progression.  What converted me from a nonbeliever to a believer?  My patients.  A number of men have come to me through the years whose PSA was rising after surgery and who subsequently embarked on stringent vegan or macrobiotic diets. Lo and behold, as long as they stayed on their diets their PSA levels would stabilize. Subsequently, T. Colin Campbell published a very convincing book called The China Study that evaluated the connection between increased animal protein intake and cancer rates.  His findings conclusively demonstrated that high animal protein intake increases cancer risk.

How can diet make such an impact?  We don’t have all the answers but there are some very logical suppositions.  First, cancer cells “hurt” people by the process of cellular multiplication, ultimately spreading throughout the body and causing organ malfunction. It’s logical to assume that “better fed” cancers, the ones that get plenty of protein and energy, will grow faster and better than cancers that are relatively deprived.  Animal protein not only provides all the necessary amino acids for the construction of new cells, animal protein is invariably accompanied by substantial amounts of a potent energy source—fat (People forget that the average hamburger is over 50% fats). High protein diets also increase the level of insulin in the blood. And high insulin levels drive sugar and protein uptake into the cancer cells, further promoting growth. And lastly, dietary cholesterol is not only a type of “fat,” but it is also a hormonal precursor, a building block for DHEA and testosterone.

Unfortunately, few of us have the ability to follow strict vegan diets. It’s a lot of work and requires constant self-denial.  Certain medications, however, can achieve some of the same effects. Metformin, a generic medication approved for the treatment of diabetes, suppresses insulin levels in the blood. Studies in diabetic men with prostate cancer who are treated with metformin have shown lower prostate cancer mortality rates compared to diabetic men who are treated with other types of diabetic medications besides metformin.  Statins pills, medications such as Lipitor and Crestor, dramatically lower cholesterol levels.  Numerous studies have reported higher cure rates in prostate cancer patients receiving radiation who are treated with statins compared to radiation-treated patients who don’t receive a statin.

Regular exercise prolongs life in cancer patients.  If we had a pill that could accomplish what exercise can do—improved energy levels, sleep, digestion, memory, longevity and less depression—everyone would take it.  Many patients are lukewarm about prescription pills like metformin and statins, probably mainly due to concerns about side effects.  But side effects can be anticipated with careful monitoring.  When a medication side effect occurs it can be detected early and when the medication is stopped the problem is almost always resolved.  Following a rigorous macrobiotic diet for the rest of your life is beyond the reach of most of us. Taking an FDA-approved pill, while using careful precautions against potential side effects, is achievable for almost all of us. 

WANT TO LEARN MORE ABOUT PROSTATE CANCER?
Register now! Join PCRI, September 11-13, 2015 for The 2015 Prostate Cancer Conference - providing educational sessions on the latest prostate cancer treatment options, lifestyle changes, and quality of life issues presented by world-renowned physicians and researchers. Hosted at The Los Angeles Airport Marriott. For more information: http://pcri.org/2015conference/
 

Tuesday, November 11, 2014

Aspirin Lowers Prostate Cancer Mortality Rates

BY MARK SCHOLZ, MD

If a man wants to tilt his odds in favor of a longer life, he wears a seat belt, eats a good diet, gets an annual medical checkup, exercises and gets married. Yes you heard me right, he gets married.  The November 2013 issue of the Journal of Clinical Oncology reports that the risk of dying from prostate cancer was 25% lower in married compared to single men.

Yet one intervention that also has merit and that often gets overlooked is the lowly aspirin pill. Aspirin is well-established as a beneficial agent for reducing cardiac risk.  It cuts the risk of heart attacks by about 30%, a rate of reduction similar to common statin medications like Lipitor and Crestor.  A risk reduction of this degree is notable considering that heart disease is the most common cause of death in men, especially in men with prostate cancer since most of them are over age 50.

I bring the issue of aspirin to light in this blog because I want to emphasize that there are further benefits of aspirin beyond the cardiac benefits. Specifically I want to cite another article published in the Journal of Clinical Oncology in October 2012, which reports that aspirin reduces prostate cancer mortality rates. Let me paraphrase the main take home message from the article: The difference in prostate cancer specific mortality between the men with prostate cancer on aspirin compared to the men with prostate not taking aspirin was most prominent in patients with high-risk disease.  The ten year prostate cancer specific mortality was only 4% in the men taking aspirin compared to 19% in the men who were not.  For men in the intermediate-risk group mortality was reduced from 6% down to 3% by taking aspirin.

So, in addition to the known cardiac benefits, aspirin also has a potent anticancer benefit.  Incidentally, other studies have shown that aspirin has an anticancer benefit for other types of cancer besides prostate cancer.

Aspirin is not totally risk free.  For example, one out of 200 can get a bleeding stomach ulcer.  People taking aspirin who develop black stools or heart burn should stop and get further medical evaluation. Despite these risks, aspirin can clearly be beneficial in a large number of people.  Just because it is cheap and readily accessible don’t be fooled into discounting its undeniable value.